Cellular 'groundskeeper' considered in cancer fight

July 30, 2014 by Rob Payne
"Autophagy is an area that potentially could make a difference in patient care and aid in the development of more effective cancer treatment," Prof Dass says. Credit: Polygon Medical Animation

A greater focus on autophagic activity and metabolism in cancerous cells could make a significant difference in the development of more effective cancer treatments, researchers contend.

Functioning as a sort of cellular groundskeeper, autophagy helps remove damaged proteins or organelles, facilitating their degradation into recyclable molecules to be released into the cytoplasm for re-use by the cell.

A catabolic process, autophagy has been linked to cancer prevention, clearing out damaged materials and promoting homeostasis (stable equilibrium between elements).

But, it has also been implicated in aiding the survival of established tumours, responding to metabolic stress to create pathways for cells to persist in cytotoxic and hypoxic conditions.

This downside has led previous researchers to focus on its role in chemotherapy and anti-cancer drug resistance.

However, Curtin University School of Pharmacy and Biosciences Research Precinct Professor Crispin Dass says understanding autophagy's dual nature is vital.

"The idea of metabolism as a target for cancer therapy is not new but was previously put aside due to the opinion that its use would be more deleterious than beneficial," he says.

"With the advances in the knowledge of the exact mechanisms and pathways involved in metabolic function, the proposal of metabolism as a target is becoming more feasible given that it can now be targeted to transformed cells, including indirectly through interactive pathways such as autophagy.

"This highlights the need to continue to pursue research into autophagy, in an attempt to truly understand its role in various cell lines and identify the variations in response to alternative stimulus."

Autophagy crucial for future treatment

Prof Dass says that without an increased focus on autophagy, and an understanding of its molecular mechanisms, significant improvements to current and future chemotherapeutic treatment may be unlikely.

"Autophagy is an area that potentially could make a difference in patient care and aid in the development of more effective ," he says.

"In an area of research where a clear majority of benchwork is devoted to finding new targets and subsequently, drugs to target these, a relook at the way the traditional drugs induce cell death in tumours may pave the way to better clinical management of this class of disease."

He says another research area of interest is exploring how such as nanoparticles made of biodegradable and 'green' resource materials can induce cell biological events in cells, including .

Explore further: Improved effectiveness of chemotherapy for cancer

Related Stories

Improved effectiveness of chemotherapy for cancer

August 15, 2013

Cancer cells often develop defence mechanisms which enable them to survive chemotherapy. A group of researchers from the Institutes of Pharmacology and Pathology in Bern present new solutions for preventing the development ...

Acidic tumour pH inhibits drug effect

February 11, 2014

Low pH in tumours counteracts the desired effect of the drug chloroquine, according to a new study from Karolinska Institutet in Sweden. The results, which are published in the journal Autophagy, might explain possible lack ...

Zombie cancer cells eat themselves to live

April 5, 2014

A University of Colorado Cancer Center study recently published in the journal Cell Reports and presented today at the American Association for Cancer Research (AACR) Annual Conference 2014 shows that the cellular process ...

Recommended for you

Scientists block breast cancer cells from hiding in bones

May 25, 2016

Scientists at the Duke Cancer Institute have identified a molecular key that breast cancer cells use to invade bone marrow in mice, where they may be protected from chemotherapy or hormonal therapies that could otherwise ...

Genetic sequencing reveals drug resistance growth

May 25, 2016

The rate at which genetically mutated cancer cells grow may help explain why patients with a common form of leukemia develop treatment resistance, according to new research led by a Weill Cornell Medicine investigator. The ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.